Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | SHMT2 | P34897 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28897158 | 0.93 | KMT2A (0.48) | ALDH1A1MEN1KMT2ARAB9AKDM4E | |
| SCHEMBL28432337 | 0.92 | CYP3A4 (0.41) | ALDH1A1MEN1KMT2ARAB9AKDM4E | |
| SCHEMBL28434585 | 0.90 | CYP3A4 (0.41) | ALDH1A1MEN1KMT2ARAB9AKDM4E | |
| SCHEMBL28440360 | 0.90 | CYP3A4 (0.41) | ALDH1A1MEN1KMT2ARAB9AKDM4E | |
| SCHEMBL28438857 | 0.90 | CYP3A4 (0.41) | ALDH1A1MEN1KMT2ARAB9AKDM4E | |
| SCHEMBL28897248 | 0.90 | CYP3A4 (0.41) | ALDH1A1MEN1KMT2ARAB9AKDM4E | |
| SCHEMBL28439505 | 0.89 | CYP3A4 (0.40) | ALDH1A1MEN1KMT2ARAB9AKDM4E | |
| SCHEMBL28443175 | 0.88 | CYP3A4 (0.40) | ALDH1A1MEN1KMT2ARAB9AKDM4E | |
| SCHEMBL30762987 | 0.88 | CYP3A4 (0.40) | ALDH1A1MEN1KMT2ARAB9AKDM4E | |
| SCHEMBL30762846 | 0.88 | CYP3A4 (0.40) | ALDH1A1MEN1KMT2ARAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111386261-A | Coumarin derivatives, preparation method thereof and application thereof in cancer treatment | 利德发现中心有限责任公司 | 2020-07-07 | — | — | CN | claimed |
| CN-111386261-A | Coumarin derivatives, preparation method thereof and application thereof in cancer treatment | 利德发现中心有限责任公司 | 2020-07-07 | — | — | CN | disclosed |